Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
"A Chat with Anat" is a series for ophthalmologists who are interested in improving delivery of care for patients living with retinal disease, and for those interested in clinically-challenging situations or controversies in care. I’m Professor Anat Loewenstein, Chair of the Department of Ophthalmology at Tel Aviv Sourasky Medical Centre in Israel, and Professor of Ophthalmology and Vice Dean at Tel Aviv University. For each episode, I will be joined by internationally renowned colleagues to discuss these important topics. This podcast series is sponsored and organized by Bayer and produced by ApotheCom.
This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise. This is not intended for UK audiences.
| Episode | Date |
|---|---|
|
The Barometer Global Survey
|
Apr 07, 2026 |
|
New options for an old disease: Treatment of CSC
|
Jan 27, 2026 |
|
Together We Care: HCP Well-being in Ophthalmology
|
Dec 05, 2025 |
|
Consensus on the diagnosis and management of simultaneous GA and CNV/MNV
|
Nov 25, 2025 |
|
From the Community, For the Community
|
Aug 07, 2025 |
|
The Hot Seat
|
Jul 08, 2025 |
|
Monitoring the fellow eye in nAMD
|
May 12, 2025 |
|
Choosing the right regimen for patients with nAMD
|
Apr 11, 2025 |
|
Revolutionizing holistic patient care: Innovations and technologies
|
Jan 08, 2025 |
|
Treatment futility and success in the context of suspending treatment
|
Nov 07, 2024 |
|
World Sight Day and collaboration for change in eye health
|
Oct 10, 2024 |
|
Equal Vision – Women in Ophthalmology
|
Sep 02, 2024 |
|
Impact of residual fluid on treatment outcomes in nAMD
|
Aug 08, 2024 |
|
Pachychoroid: Current concepts on clinical features and pathogenesis
|
Jul 08, 2024 |
|
Are we entering a new era for patients and clinicians?
|
Jun 18, 2024 |
|
Characterization of macular neovascularization subtypes in nAMD to optimize treatment outcomes
|
May 14, 2024 |
|
Optimal anti-VEGF therapy regimen
|
Sep 25, 2023 |
|
Reducing the burden of bilateral injections
|
Jul 21, 2023 |
|
Navigating anxiety and depression in patients with nAMD
|
Jan 17, 2023 |
|
Exploring the research gap of patient perspectives
|
Nov 15, 2022 |
|
Evolution of patient expectations in nAMD through the 21st century
|
Aug 19, 2022 |
|
Ways to engage with patients to enable realistic expectation-setting
|
Mar 01, 2022 |
|
How to improve your clinic organization to ensure a better patient experience, and optimize adherence to treatment
|
Oct 27, 2021 |
|
How to motivate my patient to be adherent
|
Oct 01, 2021 |